![Kyle Jenne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kyle Jenne
Corporate Officer/Principal at
IONIS PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 31/05/2026
Profile
Kyle Jenne is currently Chief Global Product Strategy Officer & EVP at Ionis Pharmaceuticals, Inc. since 2024.
Former roles include Chief Executive Officer & Director at Elsie Biotechnologies Inc., Chief Commercial Officer & Executive VP at Ionis Pharmaceuticals, Inc., and Senior Vice President-US Commercial at Akcea Therapeutics, Inc. from 2017 to 2019.
Education includes undergraduate studies at Arizona State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/04/2026 | 23,713 ( 0.01% ) | 2 M $ | 31/05/2026 |
Kyle Jenne active positions
| Companies | Position | Start |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 29/02/2024 |
Former positions of Kyle Jenne
| Companies | Position | End |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Elsie Biotechnologies Inc.
 Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Chief Executive Officer | - |
| AKCEA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Kyle Jenne
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Arizona State University
 Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Elsie Biotechnologies Inc.
Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Health Technology |
- Stock Market
- Insiders
- Kyle Jenne
